Published On: November 21, 2019Texray presented at Heart-live in Stuttgart
Heartlive is the annual congress for interventional heart medicine within the German Cardiac Society. It is designed and organized by universities, hospitals and established physicans. It is a well-attended meeting with a high number of live cases and many didactically prepared cases. Congress attendees had the opportunity to test HeadPeace and sign up for the new product, MindPeace (patent pending, 10MD, Sweden), as soon it will become available on the European market.
Published On: November 21, 2019Scientific presentation of HeadPeace
A clinical study shows that all absorbed radiation doses on the left side of the head were statistically reduced by HeadPeace.
Published On: November 21, 2019Abstract – based on Sahlgrenska university hospital and 10MD phantom study to measure reduction of radiation exposure 10MD novel products
- Accepted and presented at LINC 2020.
Published On: November 14, 2019BIBA Medical acknowledges TeXray
BIBA Medical was able to catch Petra during a busy schedule to see how launching the TeXray material on the CX Innovation platform was a great foundation to start executing...
Published On: September 30, 201910MD announces election of new Board of Directors
The shareholders of 10MD have elected Mrs Pernilla Linden and Mr Mats Alm as directors of the Board in order to strengthen and prepare the company for the market launch of HeadPeace and MindPeace.
Published On: September 10, 2019Successful verification of MindPeace in Europe
Experienced doctors acknowledged the added value of MindPeace - a new 10MD product, which expands 10MD's portfolio of products based on TeXray.
